Skip to main content

Table 1 Baseline clinical characteristics

From: CMR Characteristics, gene variants and long-term outcome in patients with left ventricular non-compaction cardiomyopathy

Parameters

LVNC (n = 28)

G+ (n = 11)

G− (n = 17)

p value*

Age, years

40.9 ± 15.1

42.1 ± 10.4

40.1 ± 17.7

0.706

Male, n (%)

20 (71.4)

7 (63.6)

13 (76.5)

0.671

BSA, m2

1.8 ± 0.2

1.9 ± 0.3

1.7 ± 0.2

0.141

Smoking, n (%)

4 (14.3)

2 (18.2)

2 (11.8)

0.454

Drinking, n (%)

2 (7.1)

1 (9.1)

1 (5.9)

0.810

Hypertension, n (%)

3 (10.7)

0 (0)

3 (17.1)

0.258

Hypercholesterolemia, n (%)

7 (25)

5 (45.5)

2 (11.8)

0.076

NYHA 3/4, n (%)

7 (25)

4 (36.8)

3 (17.6)

0.381

Family history LVNC, n (%)

3 (10.7)

2 (18.2)

1 (5.9)

0.543

Arrhythmia, n (%)

22 (78.6)

9 (81.8)

13 (76.5)

> 0.99

  1. Data are expressed as mean ± SD (standard deviation) or n (%)
  2. LVNC left ventricular non-compaction cardiomyopathy, G+ genotype positive, G− genotype negative, BSA body surface area, NYHA New York Heart Association class
  3. *Significance of difference between parameters from G+ and G− groups